New approach to evaluating the effects of a drug on protein complexes with quantitative proteomics, using the SILAC method and bioinformatic approach

References

• Phizicky EM, Fields S. Protein-protein interactions: methods for detection and analysis. Microbiol Rev. 1995 Mar;59(1):94–123.
   PubMedGoogle Scholar
• Pawson T, Nash P. Protein–protein interactions define specificity in signal transduction. Genes Dev. 2000 May;14(9):1027–1047.
   Google Scholar
• Hegele A, Kamburov A, Grossmann A, et al. Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell. 2012 Feb;45(4):567–580.
   PubMed Web of Science ®Google Scholar
• Duan XJ, Xenarios I, Eisenberg D. Describing biological protein interactions in terms of protein states and state transitions. Mol Cell Proteomics. 2002 Feb;1(2):104–116.
   PubMed Web of Science ®Google Scholar
• Zarzycka B, Kuenemann MA, Miteva MA, et al. Stabilization of protein–protein interaction complexes through small molecules. Drug Discov Today. 2016 Jan;21(1):48–57.
   PubMed Web of Science ®Google Scholar
• Archakov AI, Govorun VM, Dubanov AV, et al. Protein-protein interactions as a target for drugs in proteomics. Proteomics. 2003 Apr;3(4):380–391.
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009 Jan;10(1):57–63.
   PubMed Web of Science ®Google Scholar
• Wacker SA, Houghtaling BR, Elemento O, et al. Using transcriptome sequencing to identify mechanisms of drug action and resistance. Nat Chem Biol. 2012 Feb;8(3):235–237.
   PubMed Web of Science ®Google Scholar
• Wang S, Cheng Q. Microarray analysis in drug discovery and clinical applications. Methods Mol Biol. 2006;316:49–65.
   PubMedGoogle Scholar
• MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science. 2000 Sep;289(5485):1760–1763.
   PubMed Web of Science ®Google Scholar
• Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C. 2015 Jun;105(2):140–156.
   PubMedGoogle Scholar
• Palumbo A, Facon T, Sonneveld P, et al. Thalidomide for treatment of multiple myeloma: 10 years later. Blood. 2008 Apr;111(8):3968–3977.
   PubMed Web of Science ®Google Scholar
• Sherbet GV. Therapeutic potential of thalidomide and its analogues in the treatment of cancer. Anticancer Res. 2015 Nov;35(11):5767–5772.
   PubMed Web of Science ®Google Scholar
• Chen YY, Yen HH, Chou KC, et al. Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis. World J Gastroenterol. 2012 Feb;18(5):466–471.
   PubMed Web of Science ®Google Scholar
• Chang JY, Ka WS, Chao TY, et al. Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 2004;67(3–4):320–326.
   PubMed Web of Science ®Google Scholar
• Chen X, Wei S, Ji Y, et al. Quantitative proteomics using SILAC: principles, applications, and developments. Proteomics. 2015 Sep;15(18):3175–3192.
   PubMed Web of Science ®Google Scholar
• Bendall SC, Hughes C, Stewart MH, et al. Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics. 2008 Sep;7(9):1587–1597.
   PubMed Web of Science ®Google Scholar
• Park SS, Wu WW, Zhou Y, et al. Effective correction of experimental errors in quantitative proteomics using stable isotope labeling by amino acids in cell culture (SILAC). J Proteomics. 2012 Jun;75(12):3720–3732.
   PubMed Web of Science ®Google Scholar
• User Guide: SILAC Protein Quantitation Kits issued by Thermo Fisher Scientific (Version: MAN0016245, Rev C.0, Pub. Part No. 2161996.8). Available from: https://www.thermofisher.com/
   Google Scholar
• Zhang G, Fenyö D, Neubert TA. Evaluation of the variation in sample preparation for comparative proteomics using stable isotope labeling by amino acids in cell culture. J Proteome R. 2009 Mar;8(3):1285–1292.
   PubMed Web of Science ®Google Scholar
• Cell Lysis and Immunoprecipitation Protocol with CHAPS buffer issued by Fivephoton BiochemicalsTM. Available from: https://fivephoton.com/
   Google Scholar
• Motoyama A, Xu T, Ruse CI, et al. Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides. Anal Chem. 2007 May;79(10):3623–3634.
   PubMed Web of Science ®Google Scholar
• Gekko K, Ohmae E, Kameyama K, et al. Acetonitrile-protein interactions: amino acid solubility and preferential solvation. Biochim Biophys Acta. 1998 Sep;1387(1–2):195–205.
   PubMedGoogle Scholar
• Bobaly B, Beck A, Veuthey J-L, et al. Impact of organic modifier and temperature on protein denaturation in hydrophobic interaction chromatography. J Pharm Biomed Anal. 2016 Nov;131:124–132.
   PubMed Web of Science ®Google Scholar
• Rebecchi KR, Go EP, Xu L, et al. A general protease digestion procedure for optimal protein sequence coverage and PTM analysis of recombinant glycoproteins: application to the characterization of hLOXL2 glycosylation. Anal Chem. 2011 Nov;83(22):8484–8491.
   PubMed Web of Science ®Google Scholar
• Technical manual: Trypsin/Lys-C Mix, Mass spec grade issued by Promega (Version: TM390 Revised 2/14). Available from: https://www.promega.com/
   Google Scholar
• GL-TipTM SDB Instruction Manual issued by GL Science. Available from: http://www.glsciencesinc.com/
   Google Scholar
• Proteome Discoverer User Guide Software Version 2.2 issued by Thermo Fisher Scientific. Available from: https://www.thermofisher.com/
   Google Scholar
• Eckalbar WL, Schlebusch SA, Mason MK, et al. Transcriptomic and epigenomic characterization of the developing bat wing. Nature Genet. 2016;48(5):528–539.
   PubMed Web of Science ®Google Scholar
• Guglielmelli T, Giugliano E, Brunetto V, et al. Therapeutic potential of thalidomide and its analogues in the treatment of cancer. Oncoscience. 2015 Nov;35(11):5767–5772.
   Google Scholar
• Sherbet GV. mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein. Anticancer Res. 2015 Apr;2(4):382–394.
   Google Scholar
• Meganathan K, Jagtap S, Wagh V, et al. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One. 2012;7(8):e44228.
   PubMed Web of Science ®Google Scholar
• Tristan C, Shahani N, Sedlak TW, et al. The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal. 2011 Feb;23(2):317–323.
   PubMed Web of Science ®Google Scholar
• Proudfoot NJ. Ending the message: poly(A) signals then and now. Genes Dev. 2011 Sep;25(17):1770–1782.
   PubMed Web of Science ®Google Scholar
• Singh I, Lee SH, Sperling AS, et al. Widespread intronic polyadenylation diversifies immune cell transcriptomes. Nat Commun. 2018 Apr;9(1):1716.
   PubMedGoogle Scholar
• Gupta D, Treon SP, Shima Y, et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia. 2001 Dec;15(12):1950–1961.
   PubMed Web of Science ®Google Scholar
• Wang LH, Yang XY, Zhang X, et al. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ. Blood. 2007 Dec;110(13):4373–4384.
   PubMed Web of Science ®Google Scholar
• Parman T, Wiley MJ, Wells PG. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med. 1999 May;5(5):582–585.
   PubMed Web of Science ®Google Scholar
• Yen CH, Hsiao HH. NRF2 is one of the players involved in bone marrow mediated drug resistance in multiple myeloma. Int J Mol Sci. 2018 Nov;19(11):3503.
   Web of Science ®Google Scholar
• Shkreta L, Chabot B. The RNA splicing response to DNA damage. Biomolecules. 2015 Oct;5(4):2935–2977.
   PubMed Web of Science ®Google Scholar
• Stephens TD, Bunde CJ, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol. 2000 Jun;59(12):1489–1499.
   PubMed Web of Science ®Google Scholar
• Shin S, Wakabayashi N, Misra V, et al. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol Cell Biol. 2007 Oct;27(20):7188–7197.
   PubMed Web of Science ®Google Scholar
• Baroukia R, Coumoul X, Fernandez-Salgueroc PM. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 2007 Jul;581(19):3608–3615.
   PubMed Web of Science ®Google Scholar
• Jaeger S, Aloy P. From protein interaction networks to novel therapeutic strategies. IUBMB Life. 2012 Jun;64(6):529–537.
   PubMed Web of Science ®Google Scholar
• Perkins JR, Diboun I, Dessailly BH, et al. Transient protein-protein interactions: structural, functional, and network properties. Structure. 2010 Oct;18(10):1233–1243.
   PubMed Web of Science ®Google Scholar